OBJECTIVE: T o examine whether quality of care (QOC) improves when nurse practitioners and pharmacists work with family physicians in community practice and focus their work on patients who are 50 years of age and older and considered to be at risk of experiencing adverse health outcomes. DESIGN: Randomized controlled trial. SETTING:A family health network with 8 family physicians, 5 nurses, and 11 administrative personnel serving 10 000 patients in a rural area near Ottawa, Ont. PARTICIPANTS: Patients 50 years of age and older at risk of experiencing adverse health outcomes (N = 241). INTERVENTIONS:At-risk patients were randomly assigned to receive usual care from their family physicians or Anticipatory and Preventive Team Care (APTCare) from a collaborative team composed of their physicians, 1 of 3 nurse practitioners, and a pharmacist. MAIN OUTCOME MEASURES: Quality of care for chronic disease management (CDM) for diabetes, coronary artery disease, congestive heart failure, and chronic obstructive pulmonary disease. RESULTS: Controlling for baseline demographic characteristics, the APTCare approach improved CDM QOC by 9.2% (P < .001) compared with traditional care. The APTCare intervention also improved preventive care by 16.5% (P < .001). We did not observe significant differences in other secondary outcome measures (intermediate clinical outcomes, quality of life [Short-Form 36 and health-related quality of life scales], functional status [instrumental activities of daily living scale] and service usage). CONCLUSION: Additional resources in the form of collaborative multidisciplinary care teams with intensive interventions in primary care can improve QOC for CDM in a population of older at-risk patients. The appropriateness of this intervention will depend on its cost-effectiveness. TRIAL REGISTRATION NUMBER NCT00238836 (CONSORT).
RCT Entities:
OBJECTIVE: T o examine whether quality of care (QOC) improves when nurse practitioners and pharmacists work with family physicians in community practice and focus their work on patients who are 50 years of age and older and considered to be at risk of experiencing adverse health outcomes. DESIGN: Randomized controlled trial. SETTING: A family health network with 8 family physicians, 5 nurses, and 11 administrative personnel serving 10 000 patients in a rural area near Ottawa, Ont. PARTICIPANTS: Patients 50 years of age and older at risk of experiencing adverse health outcomes (N = 241). INTERVENTIONS: At-risk patients were randomly assigned to receive usual care from their family physicians or Anticipatory and Preventive Team Care (APTCare) from a collaborative team composed of their physicians, 1 of 3 nurse practitioners, and a pharmacist. MAIN OUTCOME MEASURES: Quality of care for chronic disease management (CDM) for diabetes, coronary artery disease, congestive heart failure, and chronic obstructive pulmonary disease. RESULTS: Controlling for baseline demographic characteristics, the APTCare approach improved CDM QOC by 9.2% (P < .001) compared with traditional care. The APTCare intervention also improved preventive care by 16.5% (P < .001). We did not observe significant differences in other secondary outcome measures (intermediate clinical outcomes, quality of life [Short-Form 36 and health-related quality of life scales], functional status [instrumental activities of daily living scale] and service usage). CONCLUSION: Additional resources in the form of collaborative multidisciplinary care teams with intensive interventions in primary care can improve QOC for CDM in a population of older at-risk patients. The appropriateness of this intervention will depend on its cost-effectiveness. TRIAL REGISTRATION NUMBER NCT00238836 (CONSORT).
Authors: Hae Mi Choe; Sonya Mitrovich; Daniel Dubay; Rodney A Hayward; Sarah L Krein; Sandeep Vijan Journal: Am J Manag Care Date: 2005-04 Impact factor: 2.229
Authors: David M Scott; Steven T Boyd; Michelle Stephan; Sam C Augustine; Thomas P Reardon Journal: Am J Health Syst Pharm Date: 2006-11-01 Impact factor: 2.637
Authors: S L Hughes; F M Weaver; A Giobbie-Hurder; L Manheim; W Henderson; J D Kubal; A Ulasevich; J Cummings Journal: JAMA Date: 2000-12-13 Impact factor: 56.272
Authors: Phayom Sookaneknun; Robert M E Richards; Jaratbhan Sanguansermsri; Chai Teerasut Journal: Ann Pharmacother Date: 2004-11-02 Impact factor: 3.154
Authors: Lisa Lim; Matthew Moore; Jennifer R DuBose; Bushra Obeidat; Robert Stroebel; Craig M Zimring Journal: J Gen Intern Med Date: 2020-05-04 Impact factor: 5.128
Authors: Myriam Soto-Gordoa; Esteban de Manuel; Ane Fullaondo; Marisa Merino; Arantzazu Arrospide; Juan Ignacio Igartua; Javier Mar Journal: Health Serv Res Date: 2018-11-22 Impact factor: 3.402